Will CEO’s New Strategy Boost Roche’s Phase III Success?
Greater Emphasis On Phase II To Boost Chances
Six months after taking the reins, Thomas Schinecker has unveiled a new approach aimed at preserving Roche’s 'R&D diversity' while cutting costly Phase III failures.
